Alain Patrick Menanga1, Christelle Kougang Ngomseu1, Ahmadou M Jingi1, Brigitte Molu Mfangam1, Jean Jacques N Noubiap1, Marie Ntep Gweth1, Kathleen Ngu Blackett1, Samuel Kingue1. 1. 1 Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon ; 2 Department of Medicine, Yaoundé General Hospital, Yaoundé, Cameroon ; 3 Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa ; 4 Medical Diagnostic Center, Yaoundé, Cameroon ; 5 Department of Medicine, Yaoundé Central Hospital, Yaoundé, Cameroon ; 6 Department of Medicine, Yaoundé Teaching Hospital, Yaoundé, Cameroon.
Abstract
BACKGROUND: Cardiovascular disease is an increasingly important issue in human immunodeficiency viral (HIV)-infected individuals. There is dearth of information on the patterns of cardiovascular disease especially in sub-Saharan Africa (SSA) patients. This study reports on the clinical, biological, electrocardiographic and echocardiographic characteristics of a group of HIV-infected patients presenting with symptoms of heart disease in Yaoundé, Cameroon. METHODS: This was a cross-sectional study conducted at the Yaoundé Central Hospital and Jamot Hospital. Consenting HIV-infected adults aged ≥18 years with symptoms suggestive of heart disease were consecutively recruited between February and July 2014. All participants underwent a complete clinical examination; biological analyses including CD4 cell counts, fasting blood glucose, and serum lipids, resting electrocardiography and cardiac ultrasound, and a venous ultrasound where necessary. RESULTS: Forty four subjects (21 men) were included. Their mean age was 48 (SD 13) years. Thirty patients (68.2%) were in WHO clinical stages 3 and 4 of HIV infection, 27 (61.4%) had a CD4 cell count <200/mm(3), and 31 (70.5%) were on antiretroviral therapy (ART). Hypertension (43.2%, n=19) was the most frequent cardiovascular risk factor; and dyslipidemia which was found in 17 subjects (38.6%) was significantly associated with ART (48.4% vs. 15.4%, P=0.04). Only men where smokers (23% vs. 0%, P=0.019). Exertional dyspnea (86.4%, n=38) and cough (59.1%, n=26) were the most frequent symptoms, and the clinical presentation was dominated by heart failure (75%, n=33). The most frequent echocardiographic abnormalities were pericardial effusion (45.5%, n=20) and dilated cardiomyopathy (22.7%, n=10). Dilated cardiomyopathy was significantly associated with CD4 cell counts <200/mm(3) (100%, P=0.003). Primary pulmonary hypertension (PH) rate was 11.4% (n=5) and all cases occurred at CD4 cell counts ≥200/mm(3) (P=0.005). The most frequent electrocardiographic abnormalities were abnormal repolarization (59%, n=26) and sinus tachycardia (56.8%, n=25). CONCLUSIONS: Cardiovascular risk factors such as hypertension and dyslipidemia are common in HIV-infected adults with heart disease in our milieu. Advanced HIV infection in adults is associated with a high rate of symptomatic heart disease, mostly effusive pericarditis and dilated cardiomyopathy. Primary PH occurred in less advanced HIV disease.
BACKGROUND:Cardiovascular disease is an increasingly important issue in humanimmunodeficiency viral (HIV)-infected individuals. There is dearth of information on the patterns of cardiovascular disease especially in sub-Saharan Africa (SSA) patients. This study reports on the clinical, biological, electrocardiographic and echocardiographic characteristics of a group of HIV-infectedpatients presenting with symptoms of heart disease in Yaoundé, Cameroon. METHODS: This was a cross-sectional study conducted at the Yaoundé Central Hospital and Jamot Hospital. Consenting HIV-infected adults aged ≥18 years with symptoms suggestive of heart disease were consecutively recruited between February and July 2014. All participants underwent a complete clinical examination; biological analyses including CD4 cell counts, fasting blood glucose, and serum lipids, resting electrocardiography and cardiac ultrasound, and a venous ultrasound where necessary. RESULTS: Forty four subjects (21 men) were included. Their mean age was 48 (SD 13) years. Thirty patients (68.2%) were in WHO clinical stages 3 and 4 of HIV infection, 27 (61.4%) had a CD4 cell count <200/mm(3), and 31 (70.5%) were on antiretroviral therapy (ART). Hypertension (43.2%, n=19) was the most frequent cardiovascular risk factor; and dyslipidemia which was found in 17 subjects (38.6%) was significantly associated with ART (48.4% vs. 15.4%, P=0.04). Only men where smokers (23% vs. 0%, P=0.019). Exertional dyspnea (86.4%, n=38) and cough (59.1%, n=26) were the most frequent symptoms, and the clinical presentation was dominated by heart failure (75%, n=33). The most frequent echocardiographic abnormalities were pericardial effusion (45.5%, n=20) and dilated cardiomyopathy (22.7%, n=10). Dilated cardiomyopathy was significantly associated with CD4 cell counts <200/mm(3) (100%, P=0.003). Primary pulmonary hypertension (PH) rate was 11.4% (n=5) and all cases occurred at CD4 cell counts ≥200/mm(3) (P=0.005). The most frequent electrocardiographic abnormalities were abnormal repolarization (59%, n=26) and sinus tachycardia (56.8%, n=25). CONCLUSIONS: Cardiovascular risk factors such as hypertension and dyslipidemia are common in HIV-infected adults with heart disease in our milieu. Advanced HIV infection in adults is associated with a high rate of symptomatic heart disease, mostly effusive pericarditis and dilated cardiomyopathy. Primary PH occurred in less advanced HIV disease.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Ahmadou M Jingi; Jean Jacques N Noubiap; Arnold Ewane Onana; Jobert Richie N Nansseu; Binhuan Wang; Samuel Kingue; André Pascal Kengne Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240
Authors: Ahmadou M Jingi; Jean Jacques N Noubiap; Edvine Wawo Yonta; Philippe Kamdem; Joël Marie Obama; Samuel Kingue Journal: Arch Public Health Date: 2014-08-04
Authors: Christine U Oramasionwu; Jonathan M Hunter; Carolyn M Brown; Gene D Morse; Kenneth A Lawson; Jim M Koeller; Christopher R Frei Journal: Open AIDS J Date: 2012-04-26
Authors: Ba Hamadou; Marie Ntep Ngweth; Miriam Megueo Fotso; Liliane Mfeukeu-Kuate; Ahmadou M Jingi; Jean Jacques Noubiap; Chris Nadege Nganou; Jerome Boombhi; Sylvie Ndongo Amougou; Alain Menanga; Samuel Kingue Journal: Cardiovasc Diagn Ther Date: 2017-12
Authors: Jean Joel R Bigna; Jobert Richie N Nansseu; Lewis N Um; Steve Raoul N Noumegni; Paule Sandra D Simé; Leopold Ndemngue Aminde; Sinata Koulla-Shiro; Jean Jacques N Noubiap Journal: BMJ Open Date: 2016-08-23 Impact factor: 2.692
Authors: Jean Joel Bigna; Jean Jacques Noubiap; Jobert Richie Nansseu; Leopold Ndemnge Aminde Journal: BMC Pulm Med Date: 2017-12-08 Impact factor: 3.317
Authors: Steve Raoul Noumegni; Jobert Richie Nansseu; Jean Joel Bigna; Vicky Jocelyne Ama Moor; Felix Kembe Assah; Mesmin Y Dehayem; Andre Pascal Kengne; Eugene Sobngwi Journal: JRSM Cardiovasc Dis Date: 2017-11-06
Authors: Félicité Kamdem; Yacouba Mapoure; Ba Hamadou; Fanny Souksouna; Marie Solange Doualla; Ahmadou Musa Jingi; Caroline Kenmegne; Fernando Kemta Lekpa; Jaff Kweban Fenkeu; Gisèle Imandy; Jean Pierre Nda Mefo'o; Henry Luma Journal: Vasc Health Risk Manag Date: 2018-12-06
Authors: Steve Raoul Noumegni; Vicky Jocelyne Moor Ama; Felix K Assah; Jean Joel Bigna; Jobert Richie Nansseu; Jenny Arielle M Kameni; Jean-Claude Katte; Mesmin Y Dehayem; Andre Pascal Kengne; Eugene Sobngwi Journal: Trop Dis Travel Med Vaccines Date: 2017-07-05